Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
使用 TORC1/2 抑制剂 TAK-228 靶向治疗晚期 NSCLC 中的 NFE2L2/KEAP1 突变
期刊:Journal of Thoracic Oncology
影响因子:21
doi:10.1016/j.jtho.2022.09.225
Paul K Paik, Pang-Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Linda Ahn, Rachel Kim, Andrew Plodkowski, Ai Ni, Jason Chang, Rachel Fanaroff, Marc Ladanyi, Elisa de Stanchina, Charles M Rudin
